Anthropomorphic lung phantom based validation of in-room proton therapy 4D-CBCT image correction for dose calculation.


Journal

Zeitschrift fur medizinische Physik
ISSN: 1876-4436
Titre abrégé: Z Med Phys
Pays: Germany
ID NLM: 100886455

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 29 05 2020
revised: 18 09 2020
accepted: 23 09 2020
pubmed: 30 11 2020
medline: 9 3 2022
entrez: 29 11 2020
Statut: ppublish

Résumé

Ventilation-induced tumour motion remains a challenge for the accuracy of proton therapy treatments in lung patients. We investigated the feasibility of using a 4D virtual CT (4D-vCT) approach based on deformable image registration (DIR) and motion-aware 4D CBCT reconstruction (MA-ROOSTER) to enable accurate daily proton dose calculation using a gantry-mounted CBCT scanner tailored to proton therapy. Ventilation correlated data of 10 breathing phases were acquired from a porcine ex-vivo functional lung phantom using CT and CBCT. 4D-vCTs were generated by (1) DIR of the mid-position 4D-CT to the mid-position 4D-CBCT (reconstructed with the MA-ROOSTER) using a diffeomorphic Morphons algorithm and (2) subsequent propagation of the obtained mid-position vCT to the individual 4D-CBCT phases. Proton therapy treatment planning was performed to evaluate dose calculation accuracy of the 4D-vCTs. A robust treatment plan delivering a nominal dose of 60Gy was generated on the average intensity image of the 4D-CT for an approximated internal target volume (ITV). Dose distributions were then recalculated on individual phases of the 4D-CT and the 4D-vCT based on the optimized plan. Dose accumulation was performed for 4D-vCT and 4D-CT using DIR of each phase to the mid position, which was chosen as reference. Dose based on the 4D-vCT was then evaluated against the dose calculated on 4D-CT both, phase-by-phase as well as accumulated, by comparing dose volume histogram (DVH) values (D Good agreement was found between the 4D-CT and 4D-vCT-based ITV-DVH curves. The relative differences ((CT-vCT)/CT) between accumulated values of ITV D Feasibility of the suggested 4D-vCT workflow using proton therapy specific imaging equipment was shown. Results indicate the potential of the method to be applied for daily 4D proton dose estimation.

Identifiants

pubmed: 33248812
pii: S0939-3889(20)30099-4
doi: 10.1016/j.zemedi.2020.09.004
pmc: PMC9948846
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-84

Informations de copyright

Copyright © 2020. Published by Elsevier GmbH.

Références

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e399-407
pubmed: 22284036
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):924-32
pubmed: 19801104
Radiat Oncol. 2018 Feb 5;13(1):19
pubmed: 29402290
Z Med Phys. 2019 Aug;29(3):249-261
pubmed: 30448049
Med Phys. 2014 Feb;41(2):021903
pubmed: 24506624
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):927-34
pubmed: 19095368
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1553-61
pubmed: 17056197
Acta Oncol. 2015;54(9):1651-7
pubmed: 26198654
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):549-559
pubmed: 27084664
Radiother Oncol. 2012 Aug;104(2):249-56
pubmed: 22809588
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1045-56
pubmed: 18029110
Phys Med Biol. 2019 Nov 15;64(22):225004
pubmed: 31610527
Radiat Oncol. 2019 Jan 25;14(1):16
pubmed: 30683133
Int J Biomed Imaging. 2011;2011:891585
pubmed: 21197460
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):919-26
pubmed: 19215826
Physiol Meas. 2011 Jan;32(1):19-34
pubmed: 21098909
IEEE Trans Med Imaging. 2009 Oct;28(10):1513-25
pubmed: 19211348
Med Phys. 2015 Mar;42(3):1354-66
pubmed: 25735290
Radiat Oncol. 2019 Oct 25;14(1):183
pubmed: 31653229
Med Phys. 2018 Nov;45(11):e1086-e1095
pubmed: 30421805
Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):424-30
pubmed: 24726289
J Xray Sci Technol. 2015;23(1):11-23
pubmed: 25567403
Phys Med Biol. 2006 Jun 7;51(11):2939-52
pubmed: 16723776
Front Oncol. 2017 Sep 05;7:201
pubmed: 28929085
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):522-30
pubmed: 17418960
Med Phys. 2005 Apr;32(4):1176-86
pubmed: 15895601
Med Phys. 2008 Sep;35(9):3998-4011
pubmed: 18841851
Phys Med Biol. 2012 Mar 21;57(6):1517-25
pubmed: 22391045
Med Phys. 2014 Mar;41(3):031703
pubmed: 24593707
Med Phys. 2001 Feb;28(2):220-31
pubmed: 11243347
Radiother Oncol. 2014 Mar;110(3):529-37
pubmed: 24424385
Phys Med Biol. 2016 Sep 21;61(18):6856-6877
pubmed: 27588815
Phys Med Biol. 2012 Jul 7;57(13):4095-115
pubmed: 22678123
Med Phys. 2015 Aug;42(8):4783-95
pubmed: 26233206
J Oncol. 2011;2011:
pubmed: 20814539
Phys Med Biol. 2015 Jan 21;60(2):595-613
pubmed: 25548912
Med Phys. 2012 Dec;39(12):7603-18
pubmed: 23231308
Med Dosim. 2018 Summer;43(2):168-176
pubmed: 29650302
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):555-61
pubmed: 17398021
Med Phys. 2013 Oct;40(10):101912
pubmed: 24089914
Phys Med Biol. 2009 Aug 7;54(15):N329-46
pubmed: 19590116
Phys Med Biol. 2012 Jun 7;57(11):R99-117
pubmed: 22571913
Radiat Oncol. 2020 Mar 5;15(1):55
pubmed: 32138753
Med Phys. 2019 Mar;46(3):1140-1149
pubmed: 30609061
Phys Med Biol. 2013 Aug 7;58(15):R131-60
pubmed: 23863203
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e427-33
pubmed: 22672753
Radiat Oncol. 2018 Oct 11;13(1):199
pubmed: 30305125
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):582-9
pubmed: 18207034

Auteurs

David Bondesson (D)

Department of Radiology, University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center (CPC-M), University Hospital, LMU Munich, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany. Electronic address: david.bondesson@med.uni-muenchen.de.

Arturs Meijers (A)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Guillaume Janssens (G)

Advanced Technology Group, Ion Beam Applications SA Louvain-la-Neuve, Belgium.

Simon Rit (S)

University of Lyon, CREATIS, CNRS UMR5220; Inserm U1044, INSA-Lyon, Université Lyon 1, Centre Léon Bérard, Lyon, France.

Moritz Rabe (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Florian Kamp (F)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Katharina Niepel (K)

Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching, Germany.

Lydia A den Otter (LAD)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Stefan Both (S)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Sebastien Brousmiche (S)

Advanced Technology Group, Ion Beam Applications SA Louvain-la-Neuve, Belgium.

Julien Dinkel (J)

Department of Radiology, University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center (CPC-M), University Hospital, LMU Munich, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany; Department of Radiology, Asklepios Lung Center Munich-Gauting, Germany.

Claus Belka (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich, Germany.

Katia Parodi (K)

Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching, Germany.

Antje Knopf (A)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Division for Medical Radiation Physics, Carl von Ossietzky Universität Oldenburg, Germany.

Christopher Kurz (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching, Germany.

Guillaume Landry (G)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching, Germany. Electronic address: Guillaume.Landry@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH